Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriers

Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriers - Study of RRSO for BRCA1/2 mutation carriers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020648

Enrollment

Registered

2016-01-20

Start date

2016-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer

Interventions

risk reducing salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.BRCA1/2 mutant carriers 2.Informed consent 3.Women who can visit our hospital to an annual follow-up survey after the surgery

Exclusion criteria

Exclusion criteria: 1.Intlerability to RRSO for other disease 2.Women with ovarian or tubal cancer 3.Women with other ovarian disease

Design outcomes

Primary

Measure	Time frame
Incidence and mortality rate of the ovarian/fallopian tube/peritoneal cancer on BRCA1/2 mutant carriers performed risk reducing salpingo-oophorectomy every year	—

Secondary

Measure	Time frame
Adverse event related to RRSO	—

Countries

Japan

Contacts

Public ContactYasuhisa Terao

Juntendo University Department of Obstetrics and Gynecology

yterao@juntendo.ac.jp03-5802-1100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026